Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will adapt and evaluate an evidence-based suicide risk screening and follow-up program in two school-based health centers in West Virginia. The suicide screening program is titled the "NIMH Clinical Pathway" and provides tools and procedures for routinely screening adolescents for suicide risk, completing risk assessments, safety planning, lethal means restriction, follow-up referrals, and other disposition planning as appropriate.
Investigators aim to do the following:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Treatment As Usual (TAU) | No Intervention | Review all medical records for patients for the standard of care used at the facility for suicide assessment and risk. Determine if the enrolled patients were assessed and if risks are present. | |
| NIMH Clinical Pathway | Active Comparator | Implementation of an adapted/tailored version of the NIMH Clinical Pathway, which identifies a workflow and tools for routine suicide risk screening, assessment, safety planning and follow-up. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| NIMH Clinical Pathway | Behavioral | Complete the implemented workflow and tools for suicide risk screening, assessment, safety planning and follow-up. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of Patients Screened for Suicidal Risks-Site 1 | Review of patient records for the number of patients that were asked about suicidal thoughts and/or behaviors during their visit. Review will occur for a total of 3 months during the Treatment as Usual Period. | Total period of 3 Months |
| Number of Patients Screened for Suicidal Risks-Site 2 | Review of patient records for the number of patients that were asked about suicidal thoughts and/or behaviors during their visit. Review will occur for a total of 6 months during the Treatment as Usual Period. | Total period of 6 Months |
| Number of Patients Reporting Suicidal Risks-Site 1 | Review of patient records for the number of patients that reported having suicidal thoughts and/or behaviors. Review will occur for a total of 12 months during the Intervention Period. | Total period of 12 Months |
| Number of Patients Reporting Suicidal Risks-Site 2 | Review of patient records for the number of patients that reported having suicidal thoughts and/or behaviors. Review will occur for a total of 12 months during the Interventional Period | Total period of 12 Months |
| Measure | Description | Time Frame |
|---|---|---|
| Safety Planning Rates (Number)- Site 1 | Number of at-risk patients that the providers documented safety planning was completed. | Initial Visit |
| Safety Planning Rates (Number)- Site 1 | Number of at-risk patients that the providers documented safety planning was completed. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Mary Christensen, PhD, LICSW | Contact | 304-293-3501 | mary.christensen@mail.wvu.edu |
| Name | Affiliation | Role |
|---|---|---|
| Mary Christensen, PhD, LICSW | West Virginia University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| West Virginia University | Recruiting | Morgantown | West Virginia | 26505 | United States |
Not provided
| ID | Term |
|---|---|
| D000092864 | Suicide Prevention |
| D013405 | Suicide |
| ID | Term |
|---|---|
| D016728 | Self-Injurious Behavior |
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 3 Month Follow Up Visit |
| Safety Planning Rates (Number)- Site 2 | Number of at-risk patients that the providers documented safety planning was completed. | Initial Visit |
| Safety Planning Rates (Number)- Site 2 | Number of at-risk patients that the providers documented safety planning was completed. | 3 Month Follow Up Visit |
| Safety Planning Rates (Percentage)- Site 1 | Percentage of at-risk patients that the providers documented safety planning was completed. | Initial Visit |
| Safety Planning Rates (Percentage)- Site 1 | Percentage of at-risk patients that the providers documented safety planning was completed. | 3 Month Follow Up Visit |
| Safety Planning Rates (Percentage)- Site 2 | Percentage of at-risk patients that the providers documented safety planning was completed. | Initial Visit |
| Safety Planning Rates (Percentage)- Site 2 | Percentage of at-risk patients that the providers documented safety planning was completed. | 3 Month Follow Up Visit |
| Follow-up Service Provision (Number)- Site 1 | Number of at-risk patients that documentation confirms providers conducted follow-up appointments to re-assess suicidal symptoms. | Chart review conducted within 3 months following initial visit |
| Follow-up Service Provision (Number)- Site 2 | Number of at-risk patients that documentation confirms providers conducted follow-up appointments to re-assess suicidal symptoms. | Chart review conducted within 3 months following initial visit |
| Participant rate of Suicidal Ideation: (SIQ-Jr)- Site 1 | Suicidal Ideation Questionnaire (SIQ-Jr) will be administered to participants at the initial visit and 3 months follow up. The SIQ-Jr is a 15-item self-report questionnaire that measures suicidal thoughts on a 7-point scale ("0- I never had this thought" to "6- I have this thought every day"). Scores range from 0-90, SIQ-Jr scores of 23 and above indicate severe suicidal ideation and the need for clinical intervention. | Initial Visit |
| Participant rate of Suicidal Ideation: (SIQ-Jr)- Site 1 | Suicidal Ideation Questionnaire (SIQ-Jr) will be administered to participants at the initial visit and 3 months follow up. The SIQ-Jr is a 15-item self-report questionnaire that measures suicidal thoughts on a 7-point scale ("0- I never had this thought" to "6- I have this thought every day"). Scores range from 0-90, SIQ-Jr scores of 23 and above indicate severe suicidal ideation and the need for clinical intervention. | 3 Month Follow Up Visit |
| Participant rate of Suicidal Ideation: (SIQ-Jr)- Site 2 | Suicidal Ideation Questionnaire (SIQ-Jr) will be administered to participants at the initial visit and 3 months follow up. The SIQ-Jr is a 15-item self-report questionnaire that measures suicidal thoughts on a 7-point scale ("0- I never had this thought" to "6- I have this thought every day"). Scores range from 0-90, SIQ-Jr scores of 23 and above indicate severe suicidal ideation and the need for clinical intervention. | Initial visit |
| Participant rate of Suicidal Ideation: (SIQ-Jr)- Site 2 | Suicidal Ideation Questionnaire (SIQ-Jr) will be administered to participants at the initial visit and 3 months follow up. The SIQ-Jr is a 15-item self-report questionnaire that measures suicidal thoughts on a 7-point scale ("0- I never had this thought" to "6- I have this thought every day"). Scores range from 0-90, SIQ-Jr scores of 23 and above indicate severe suicidal ideation and the need for clinical intervention. | 3 Month Follow Up Visit |
| Participant rate of Depression: (CES-D)- Site 1 | The Center for Epidemiological Studies Depression Scale (CES-D) will be administered to the participant at the initial visit and the 3 month follow up. The CES-D is a self-report measure with 10 items asking about the frequency with which individuals have experienced various symptoms of depression within the last week. Each item is rated on a Likert scale, typically ranging from 0 (rarely or none of the time) to 3 (most or all of the time). Total scores range is from 0-30, with higher scores indicating higher levels of depression. | Initial Visit |
| Participant rate of Depression: (CES-D)- Site 1 | The Center for Epidemiological Studies Depression Scale (CES-D) will be administered to the participant at the initial visit and the 3 month follow up. The CES-D is a self-report measure with 10 items asking about the frequency with which individuals have experienced various symptoms of depression within the last week. Each item is rated on a Likert scale, typically ranging from 0 (rarely or none of the time) to 3 (most or all of the time). Total scores range is from 0-30, with higher scores indicating higher levels of depression. | 3 Month Follow Up Visit |
| Participant rate of Depression: (CES-D)- Site 2 | The Center for Epidemiological Studies Depression Scale (CES-D) will be administered to the participant at the initial visit and the 3 month follow up. The CES-D is a self-report measure with 10 items asking about the frequency with which individuals have experienced various symptoms of depression within the last week. Each item is rated on a Likert scale, typically ranging from 0 (rarely or none of the time) to 3 (most or all of the time). Total scores range is from 0-30, with higher scores indicating higher levels of depression. | Initial Visit |
| Participant rate of Depression: (CES-D)- Site 2 | The Center for Epidemiological Studies Depression Scale (CES-D) will be administered to the participant at the initial visit and the 3 month follow up. The CES-D is a self-report measure with 10 items asking about the frequency with which individuals have experienced various symptoms of depression within the last week. Each item is rated on a Likert scale, typically ranging from 0 (rarely or none of the time) to 3 (most or all of the time). Total scores range is from 0-30, with higher scores indicating higher levels of depression. | 3 Month Follow Up Visit |
| Participants with Suicidal Behavior at Follow Up (Number)- Site 1 | Number of participants who indicate "yes" as per the following: Providers will administer the brief version of the Columbia Suicide-Severity Rating Scale (C-SSRS). The C-SSRS is a screening tool that asks two initial questions about suicidal ideation. For participants who state "yes" to either of these questions, they are asked additional questions about suicidal intent, plans, and behavior. Investigators will measure suicidal behavior as a dichotomous "yes"/"no" variable. A participant will be considered a "yes" for this measure if they answer "yes" to the final question about engaging in suicidal preparation and/or attempts on the C-SSRS and to the question asking whether or not they have done so in the past 3 months. | 3 Month Follow Up Visit |
| Participants with Suicidal Behavior at Follow Up (Number)- Site 2 | Number of participants who indicate "yes" as per the following: Providers will administer the brief version of the Columbia Suicide-Severity Rating Scale (C-SSRS). The C-SSRS is a screening tool that asks two initial questions about suicidal ideation. For participants who state "yes" to either of these questions, they are asked additional questions about suicidal intent, plans, and behavior. Investigators will measure suicidal behavior as a dichotomous "yes"/"no" variable. A participant will be considered a "yes" for this measure if they answer "yes" to the final question about engaging in suicidal preparation and/or attempts on the C-SSRS and to the question asking whether or not they have done so in the past 3 months. | 3 Month Follow Up Visit |
| Participants with Suicidal Behavior at Follow Up (Percentage)- Site 1 | Percentage of participants who indicate "yes" as per the following: Providers will administer the brief version of the Columbia Suicide-Severity Rating Scale (C-SSRS). The C-SSRS is a screening tool that asks two initial questions about suicidal ideation. For participants who state "yes" to either of these questions, they are asked additional questions about suicidal intent, plans, and behavior. Investigators will measure suicidal behavior as a dichotomous "yes"/"no" variable. A participant will be considered a "yes" for this measure if they answer "yes" to the final question about engaging in suicidal preparation and/or attempts on the C-SSRS and to the question asking whether or not they have done so in the past 3 months. | 3 Month Follow Up Visit |
| Participants with Suicidal Behavior at Follow Up (Percentage)- Site 2 | Percentage of participants who indicate "yes" as per the following: Providers will administer the brief version of the Columbia Suicide-Severity Rating Scale (C-SSRS). The C-SSRS is a screening tool that asks two initial questions about suicidal ideation. For participants who state "yes" to either of these questions, they are asked additional questions about suicidal intent, plans, and behavior. Investigators will measure suicidal behavior as a dichotomous "yes"/"no" variable. A participant will be considered a "yes" for this measure if they answer "yes" to the final question about engaging in suicidal preparation and/or attempts on the C-SSRS and to the question asking whether or not they have done so in the past 3 months. | 3 Month Follow Up Visit |
| Participants Reporting Safety Plan Usage (Number) - Site 1 | Number of participants who screen positive for suicide risk during the initial visit reporting use of the safety plan developed for the participant. | 3 Month Follow Up Visit |
| Participants Reporting Safety Plan Usage (Number)- Site 2 | Number of participants who screen positive for suicide risk during the initial visit reporting use of the safety plan developed for the participant. | 3 Month Follow Up Visit |
| Participants Reporting Safety Plan Usage (Percentage)- Site 1 | Percentage of participants who screen positive for suicide risk during the initial visit reporting use of the safety plan developed for the participant. | 3 Month Follow Up Visit |
| Participants Reporting Safety Plan Usage (Percentage)- Site 2 | Percentage of participants who screen positive for suicide risk during the initial visit reporting use of the safety plan developed for the participant. | 3 Month Follow Up Visit |
| Parents Reporting Safety Plan Usage (Number)- Site 1 | Number of parents whose child screened positive for suicide risk during the initial visit reporting the use of the safety plan that was developed for the participant (child). | 3 Month Follow Up Visit |
| Parents Reporting Safety Plan Usage (Number)- Site 2 | Number of parents whose child screened positive for suicide risk during the initial visit reporting the use of the safety plan that was developed for the participant (child). | 3 Month Follow Up Visit |
| Parents Reporting Safety Plan Usage (Percentage)- Site 1 | Percentage of parents whose child screened positive for suicide risk during the initial visit reporting the use of the safety plan that was developed for the participant (child). | 3 Month Follow Up Visit |
| Parents Reporting Safety Plan Usage (Percentage)- Site 2 | Percentage of parents whose child screened positive for suicide risk during the initial visit reporting the use of the safety plan that was developed for the participant (child). | 3 Month Follow Up Visit |
| Participants Reporting Frequency of Safety Plan Use (Number)- Site 1 | Number of participants who endorse each category related to Safety Plan Usage. Measured on a Likert Type scale with a range of 1-5 ("1-all the time," "2-often," "3-sometimes," "4-almost never," or "5-never") with 1 being more frequent usage and 5 being less frequent usage. | 3 Month Follow Up Visit |
| Participants Reporting Frequency of Safety Plan Use (Number)- Site 2 | Number of participants who endorse each category related to Safety Plan Usage. Measured on a Likert Type scale with a range of 1-5 ("1-all the time," "2-often," "3-sometimes," "4-almost never," or "5-never") with 1 being more frequent usage and 5 being less frequent usage. | 3 Month Follow Up Visit |
| Participants Reporting Frequency of Safety Plan Use (Percentage)- Site 1 | Percentage of participants who endorse each category related to Safety Plan Usage. Measured on a Likert Type scale with a range of 1-5 ("1-all the time," "2-often," "3-sometimes," "4-almost never," or "5-never") with 1 being more frequent usage and 5 being less frequent usage. | 3 Month Follow Up Visit |
| Participants Reporting Frequency of Safety Plan Use (Percentage)- Site 2 | Percentage of participants who endorse each category related to Safety Plan Usage. Measured on a Likert Type scale with a range of 1-5 ("1-all the time," "2-often," "3-sometimes," "4-almost never," or "5-never") with 1 being more frequent usage and 5 being less frequent usage. | 3 Month Follow Up Visit |
| Parents Reporting Frequency of Safety Plan Use (Number)- Site 1 | Number of parents who endorse each category related to Safety Plan Usage. Measured on a Likert Type scale with a range of 1-5 ("1-all the time," "2-often," "3-sometimes," "4-almost never," or "5-never") with 1 being more frequent usage and 5 being less frequent usage. | 3 Month Follow Up Visit |
| Parents Reporting Frequency of Safety Plan Use (Number)- Site 2 | Number of parents who endorse each category related to Safety Plan Usage. Measured on a Likert Type scale with a range of 1-5 ("1-all the time," "2-often," "3-sometimes," "4-almost never," or "5-never") with 1 being more frequent usage and 5 being less frequent usage. | 3 Month Follow Up Visit |
| Parents Reporting Frequency of Safety Plan Use (Percentage)- Site 1 | Percentage of parents who endorse each category related to Safety Plan Usage. Measured on a Likert Type scale with a range of 1-5 ("1-all the time," "2-often," "3-sometimes," "4-almost never," or "5-never") with 1 being more frequent usage and 5 being less frequent usage. | 3 Month Follow Up Visit |
| Parents Reporting Frequency of Safety Plan Use (Percentage)- Site 2 | Percentage of parents who endorse each category related to Safety Plan Usage. Measured on a Likert Type scale with a range of 1-5 ("1-all the time," "2-often," "3-sometimes," "4-almost never," or "5-never") with 1 being more frequent usage and 5 being less frequent usage. | 3 Month Follow Up Visit |
| Participants Reporting Helpfulness of Safety Plan (Number)- Site 1 | Number of participants who endorse each category related to Safety Plan Helpfulness. Measured on a Likert Type scale with a range of 1-4 ("1-very helpful," "2-helpful," "3-a little helpful," or "4-not at all helpful.") with 1 being most helpful and 4 being least helpful. | 3 Month Follow Up Visit |
| Participants Reporting Helpfulness of Safety Plan (Number)- Site 2 | Number of participants who endorse each category related to Safety Plan Helpfulness. Measured on a Likert Type scale with a range of 1-4 ("1-very helpful," "2-helpful," "3-a little helpful," or "4-not at all helpful.") with 1 being most helpful and 4 being least helpful. | 3 Month Follow Up Visit |
| Participants Reporting Helpfulness of Safety Plan (Percentage)- Site 1 | Percentage of participants who endorse each category related to Safety Plan Helpfulness. Measured on a Likert Type scale with a range of 1-4 ("1-very helpful," "2-helpful," "3-a little helpful," or "4-not at all helpful.") with 1 being most helpful and 4 being least helpful. | 3 Month Follow Up Visit |
| Participants Reporting Helpfulness of Safety Plan (Percentage)- Site 2 | Percentage of participants who endorse each category related to Safety Plan Helpfulness. Measured on a Likert Type scale with a range of 1-4 ("1-very helpful," "2-helpful," "3-a little helpful," or "4-not at all helpful.") with 1 being most helpful and 4 being least helpful. | 3 Month Follow Up Visit |
| Parents Reporting Helpfulness of Safety Plan (Number)- Site 1 | Number of parents who endorse each category related to Safety Plan Helpfulness. Measured on a Likert Type scale with a range of 1-4 ("1-very helpful," "2-helpful," "3-a little helpful," or "4-not at all helpful.") with 1 being most helpful and 4 being least helpful. | 3 Month Follow Up Visit |
| Parents Reporting Helpfulness of Safety Plan (Number)- Site 2 | Number of parents who endorse each category related to Safety Plan Helpfulness. Measured on a Likert Type scale with a range of 1-4 ("1-very helpful," "2-helpful," "3-a little helpful," or "4-not at all helpful.") with 1 being most helpful and 4 being least helpful. | 3 Month Follow Up Visit |
| Parents Reporting Helpfulness of Safety Plan (Percentage)- Site 1 | Percentage of parents who endorse each category related to Safety Plan Helpfulness. Measured on a Likert Type scale with a range of 1-4 ("1-very helpful," "2-helpful," "3-a little helpful," or "4-not at all helpful.") with 1 being most helpful and 4 being least helpful. | 3 Month Follow Up Visit |
| Parents Reporting Helpfulness of Safety Plan (Percentage)- Site 2 | Percentage of parents who endorse each category related to Safety Plan Helpfulness. Measured on a Likert Type scale with a range of 1-4 ("1-very helpful," "2-helpful," "3-a little helpful," or "4-not at all helpful.") with 1 being most helpful and 4 being least helpful. | 3 Month Follow Up Visit |
| Participants Reporting Acute Care Usage (Number)- Site 1 | Number of participants who report acute care was utilized for help with suicidal symptoms between the initial visit and the 3 month follow up visit per participant report. | Total period of 3 Months |
| Participants Reporting Acute Care Usage (Number)- Site 2 | Number of participants who reported acute care was utilized for help with suicidal symptoms between the initial visit and the 3 month follow up visit per participant report. | Total period of 3 Months |
| Participants Reporting Acute Care Usage (Percentage)- Site 1 | Percentage of participants that reported acute care was utilized for help with suicidal symptoms between the initial visit and the 3 month follow up visit. | Total period of 3 Months |
| Participants Reporting Acute Care Usage (Percentage)- Site 2 | Percentage of participants that reported acute care was utilized for help with suicidal symptoms between the initial visit and the 3 month follow up visit. | Total period of 3 Months |
| Parents Reporting Acute Care Usage (Number)- Site 1 | Number of parents who report a participant utilized acute care for help with suicidal symptoms between the initial visit and the 3 month follow up visit as per reported by the parent. | Total period of 3 Months |
| Parents Reporting Acute Care Usage (Number)- Site 2 | Number of parents who report a participant utilized acute care for help with suicidal symptoms between the initial visit and the 3 month follow up visit as per reported by the parent. | Total period of 3 Months |
| Parents Reporting Acute Care Usage (Percentage)- Site 1 | Percentage of parents that reported acute care was utilized for help with participant suicidal symptoms between the initial visit and the 3 month follow up visit. | Total period of 3 Months |
| Parents Reporting Acute Care Usage (Percentage)- Site 2 | Percentage of parents that reported acute care was utilized for help with participant suicidal symptoms between the initial visit and the 3 month follow up visit. | Total period of 3 Months |